(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202312 | 202212 | % Var | 202312 | 202212 | % Var | 202303 | 202203 | % Var | |
| Sales | 32.10 | 32.57 | -1.44 | 106.91 | 94.47 | 13.17 | 120.72 | 140.90 | -14.32 |
| Other Income | 0.06 | 0.23 | -73.91 | 1.76 | 1.12 | 57.14 | 2.01 | 1.06 | 89.62 |
| PBIDT | 2.33 | 1.86 | 25.27 | 7.90 | 6.34 | 24.61 | 9.62 | 11.97 | -19.63 |
| Interest | 0.41 | 0.04 | 925.00 | 0.74 | 0.10 | 640.00 | 0.54 | 0.25 | 116.00 |
| PBDT | 1.92 | 1.82 | 5.49 | 7.16 | 6.24 | 14.74 | 9.08 | 11.72 | -22.53 |
| Depreciation | 0.33 | 0.32 | 3.13 | 0.99 | 0.96 | 3.13 | 1.29 | 1.30 | -0.77 |
| PBT | 1.59 | 1.50 | 6.00 | 6.17 | 5.28 | 16.86 | 7.79 | 10.42 | -25.24 |
| TAX | 0.41 | 0.35 | 17.14 | 1.51 | 1.30 | 16.15 | 2.02 | 2.38 | -15.13 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.08 | -0.12 | -33.33 |
| PAT | 1.18 | 1.15 | 2.61 | 4.66 | 3.98 | 17.09 | 5.77 | 8.04 | -28.23 |
| Equity | 29.90 | 29.90 | 0.00 | 29.90 | 29.90 | 0.00 | 29.90 | 29.90 | 0.00 |
| PBIDTM(%) | 7.26 | 5.71 | 27.10 | 7.39 | 6.71 | 10.11 | 7.97 | 8.50 | -6.20 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: